Search the Newsreel

IMUNON's IMNN-001 shows promising Phase 2 ovarian cancer data with improved disease clearance and safety.

IMUNON, Inc. announced positive preliminary Phase 2 data for its DNA-mediated immunotherapy IMNN-001 in advanced ovarian cancer. The study showed lower minimal residual disease rates and higher circulating tumor DNA clearance, along with a favorable safety profile. These results support IMNN-001's potential to improve …

IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer

IMUNON announced positive preliminary Phase 2 clinical data for its IMNN-001 immunotherapy in newly diagnosed advanced ovarian cancer. The study, conducted in partnership with Break Through Cancer, showed a lower minimal residual disease (MRD)-positive rate, higher circulating tumor DNA (ctDNA) clearance, and a highly …

Precision Trading with Simulations Plus Inc. (SLP) Risk Zones

Simulations Plus Inc. (SLP) is showing a neutral sentiment across all horizons, leading to a wait-and-see approach. AI models suggest several trading strategies, including a short setup with a high risk-reward ratio, targeting a 16.5% downside. The article details entry, target, and stop-loss zones …

Simulations Plus (NASDAQ:SLP) Share Price Crosses Above 200-Day Moving Average - Time to Sell?

Simulations Plus (NASDAQ: SLP) saw its share price move above its 200-day moving average, reaching $18.25 despite cautious analyst sentiment and recent downgrades. The company reported strong quarterly earnings, beating expectations with an EPS of $0.30 and revenue of $21.89 million. While a director …

Simulations Plus (SLP) to go private in $375M all‑cash sale to Altaris

Simulations Plus (SLP) is set to go private through a $375 million all-cash sale to Altaris, with shareholders receiving $18.50 per share. This represents a 26% premium over the 60-day volume-weighted average price prior to June 15, 2026. The acquisition is expected to close …

ETFs Investing in Replimune Group, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Replimune Group, Inc. (A2JQN1) stocks, offering investors diversified exposure to the company. The ETFs are sorted by their market value of Replimune holdings and include details such as issuer, management style, expense ratio, AUM, …

Yimutian (NasdaqCM:YMT) Stock Price

Yimutian Inc. (NasdaqCM:YMT) has a market cap of US$2.5 million and is described as low risk and slightly overvalued. The company recently announced the full deployment of its WolaiCai AI Agent across all platforms, which is generating significant daily revenue and has increased potato …

Simulations Plus | 144: Notice of proposed sale of securities pursuant to Rule 144

This document is a formal notification regarding the proposed sale of securities by Simulations Plus, carried out under Rule 144 of the Securities Act of 1933. Rule 144 allows for the public resale of restricted and control securities if certain conditions are met. The …

Lobbying Update: $80,000 of MAXIMUS INC. lobbying was just disclosed

A recent Lobbying Disclosure Act filing revealed that MAXIMUS INC. spent $80,000 on lobbying during Q2 2026, primarily on "Workforce issues." The article also details recent insider trading activity for MMS, including purchases by the CEO and CFO, and sales by another executive. Additionally, …

Simulations Plus: The Potential Little Spread Is Not Worth The Risk For New Money, Hold

Maximus stock trades near highs as Medicaid and veterans contracts support growth

Maximus stock is performing well due to increasing revenue from government service contracts, particularly in Medicaid and veterans services, and a substantial contract backlog. The company's focus on technology and digital services, alongside careful cost management and strategic contracts, supports its growth. Investors are …

Lobbying Update: $80,000 of OPTIMUM COMMUNICATIONS (FORMERLY REPORTING AS ALTICE USA INC.) lobbying was just disclosed

Optimum Communications, formerly Altice USA Inc., recently disclosed $80,000 in lobbying expenditures for Q2 2026. The lobbying efforts focused on issues related to broadband deployment, affordability, programming agreements, marketplace dynamics, and broadcast ownership rules. This information was released in a new Lobbying Disclosure Act …

Maximus (MMS) Stock Looks Below Fair Value While Earnings Face Budget Risk

Maximus (MMS) stock has experienced a 33.0% decline year-to-date but appears undervalued based on several fundamental measures, trading at a significant discount to its industry and peer P/E averages. The company's valuation is influenced by its reliance on government contracts, making it susceptible to …

Maximus (MMS) Affirms Dividend, Is The Stock Trading At A Discount?

Maximus (MMS) has declared a quarterly cash dividend of $0.33 per share, payable on August 31, 2026. Despite recent share price momentum, the stock is trading significantly below analyst targets and fair value estimates. Analysts see the company as undervalued due to its role …

Liquidity Mapping Around (REPL) Price Events

This article analyzes Replimune Group Inc. (NASDAQ: REPL) stock, identifying weak near- and mid-term sentiment with a neutral long-term outlook. It highlights an exceptional risk-reward short setup and provides three AI-generated trading strategies tailored for different risk profiles: Position Trading, Momentum Breakout, and Risk …

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Replimune Group, Inc. (REPL)

Johnson Fistel, PLLP is investigating potential breach of fiduciary duty claims against officers and directors of Replimune Group, Inc. (REPL) on behalf of long-term shareholders who held shares continuously since prior to November 22, 2024. The investigation stems from allegations that Replimune made misleading …

SIMULATIONS PLUS ($SLP) Releases Q3 2026 Earnings

Simulations Plus (NASDAQ: SLP) grows Q3 2026 revenue 7% to $21.9M

Spotting Winners: Optimum Communications (NYSE:OPTU) And Consumer Discretionary - Wireless, Cable and Satellite Stocks In Q1

OPTU Stock Slips As Heavy Losses Clash With Strong Revenue

Simulations Plus stock downgraded by William Blair on Altaris deal

With $21.8B in debt at unit, Optimum launches $2.50 tender offer

Optimum Communications Q1 Earnings Call Highlights

Optimum Communications (OPTU) Q1 Loss Of US$2.9b Reinforces Bearish Margin Narratives

Optimum Communications Q1 Earnings Beat Estimates on Cost Discipline

Optimum Communications, Inc. (OPTU) Reports Q1 Loss, Lags Revenue Estimates

Optimum Communications, Inc. 2026 Q1 - Results - Earnings Call Presentation (NYSE:OPTU) 2026-05-07

Optimum Communications (NYSE:OPTU) Posts Q1 CY2026 Sales In Line With Estimates

Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development

Simulations Plus Q2 Earnings Call Highlights

Simulations Plus (SLP) Quarterly Profit Tests Bearish Narratives On Earnings Decline

Why Simulations Plus Stock Inched Higher Today

Simulations Plus Q2 Earnings & Revenues Beat, Jump Y/Y, Shares Soar

Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results

Simulations Plus (SLP) Beats Q2 Earnings and Revenue Estimates

Simulations Plus (SLP) Releases Q2 2026 Earnings: Revenue and EPS Beat, Operating Profit Surges | SLP Stock News